S&P 500   3,977.53 (+0.16%)
DOW   32,432.08 (+0.60%)
QQQ   308.76 (-0.69%)
AAPL   158.28 (-1.23%)
MSFT   276.38 (-1.49%)
META   202.84 (-1.54%)
GOOGL   102.46 (-2.83%)
AMZN   98.04 (-0.09%)
TSLA   191.81 (+0.74%)
NVDA   265.31 (-0.93%)
NIO   8.93 (-1.54%)
BABA   86.12 (-0.90%)
AMD   96.61 (-1.37%)
T   18.87 (+1.40%)
F   11.52 (+0.09%)
MU   59.79 (-2.24%)
CGC   1.88 (-1.05%)
GE   93.31 (+2.12%)
DIS   95.62 (+1.64%)
AMC   4.55 (+1.79%)
PFE   40.22 (-0.42%)
PYPL   73.30 (-0.79%)
NFLX   327.66 (-0.22%)
S&P 500   3,977.53 (+0.16%)
DOW   32,432.08 (+0.60%)
QQQ   308.76 (-0.69%)
AAPL   158.28 (-1.23%)
MSFT   276.38 (-1.49%)
META   202.84 (-1.54%)
GOOGL   102.46 (-2.83%)
AMZN   98.04 (-0.09%)
TSLA   191.81 (+0.74%)
NVDA   265.31 (-0.93%)
NIO   8.93 (-1.54%)
BABA   86.12 (-0.90%)
AMD   96.61 (-1.37%)
T   18.87 (+1.40%)
F   11.52 (+0.09%)
MU   59.79 (-2.24%)
CGC   1.88 (-1.05%)
GE   93.31 (+2.12%)
DIS   95.62 (+1.64%)
AMC   4.55 (+1.79%)
PFE   40.22 (-0.42%)
PYPL   73.30 (-0.79%)
NFLX   327.66 (-0.22%)
S&P 500   3,977.53 (+0.16%)
DOW   32,432.08 (+0.60%)
QQQ   308.76 (-0.69%)
AAPL   158.28 (-1.23%)
MSFT   276.38 (-1.49%)
META   202.84 (-1.54%)
GOOGL   102.46 (-2.83%)
AMZN   98.04 (-0.09%)
TSLA   191.81 (+0.74%)
NVDA   265.31 (-0.93%)
NIO   8.93 (-1.54%)
BABA   86.12 (-0.90%)
AMD   96.61 (-1.37%)
T   18.87 (+1.40%)
F   11.52 (+0.09%)
MU   59.79 (-2.24%)
CGC   1.88 (-1.05%)
GE   93.31 (+2.12%)
DIS   95.62 (+1.64%)
AMC   4.55 (+1.79%)
PFE   40.22 (-0.42%)
PYPL   73.30 (-0.79%)
NFLX   327.66 (-0.22%)
S&P 500   3,977.53 (+0.16%)
DOW   32,432.08 (+0.60%)
QQQ   308.76 (-0.69%)
AAPL   158.28 (-1.23%)
MSFT   276.38 (-1.49%)
META   202.84 (-1.54%)
GOOGL   102.46 (-2.83%)
AMZN   98.04 (-0.09%)
TSLA   191.81 (+0.74%)
NVDA   265.31 (-0.93%)
NIO   8.93 (-1.54%)
BABA   86.12 (-0.90%)
AMD   96.61 (-1.37%)
T   18.87 (+1.40%)
F   11.52 (+0.09%)
MU   59.79 (-2.24%)
CGC   1.88 (-1.05%)
GE   93.31 (+2.12%)
DIS   95.62 (+1.64%)
AMC   4.55 (+1.79%)
PFE   40.22 (-0.42%)
PYPL   73.30 (-0.79%)
NFLX   327.66 (-0.22%)
OTCMKTS:KALTF

Claritas Pharmaceuticals - KALTF Competitors

$0.01
0.00 (0.00%)
(As of 03/24/2023 12:00 AM ET)
Add
Compare
Today's Range
$0.01
▼
$0.01
50-Day Range
$0.01
▼
$0.08
52-Week Range
$0.03
▼
$1.36
Volume
N/A
Average Volume
9,705 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

KALTF vs. TRSBF, ATTBF, ABCZF, ADOIF, AIMDW, AGNPF, AKBLF, LBTSF, ALPX, and DRTSW

Should you be buying Claritas Pharmaceuticals stock or one of its competitors? The main competitors of Claritas Pharmaceuticals include 3SBio (TRSBF), Abattis Bioceuticals (ATTBF), Abcam (ABCZF), Adocia (ADOIF), Ainos (AIMDW), Algernon Pharmaceuticals (AGNPF), ALK-Abelló A/S (AKBLF), Almirall (LBTSF), Alopexx (ALPX), and Alpha Tau Medical (DRTSW). These companies are all part of the "biotechnology" industry.

Claritas Pharmaceuticals vs.

3SBio (OTCMKTS:TRSBF) and Claritas Pharmaceuticals (OTCMKTS:KALTF) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their media sentiment, risk, institutional ownership, valuation, profitability, earnings, analyst recommendations, dividends and community ranking.

In the previous week, 3SBio had 1 more articles in the media than Claritas Pharmaceuticals. MarketBeat recorded 1 mentions for 3SBio and 0 mentions for Claritas Pharmaceuticals. 3SBio's average media sentiment score of 0.00 equaled Claritas Pharmaceuticals' average media sentiment score.

Company Overall Sentiment
3SBio Neutral
Claritas Pharmaceuticals Neutral

Claritas Pharmaceuticals received 65 more outperform votes than 3SBio when rated by MarketBeat users.

CompanyUnderperformOutperform
3SBioN/AN/A
Claritas PharmaceuticalsOutperform Votes
65
73.03%
Underperform Votes
24
26.97%

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
3SBioN/AN/AN/AN/AN/A
Claritas PharmaceuticalsN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
3SBio N/A N/A N/A
Claritas Pharmaceuticals N/A N/A N/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
3SBio
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Claritas Pharmaceuticals
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Summary

3SBio and Claritas Pharmaceuticals tied by winning 1 of the 2 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding KALTF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of OTCMKTS and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

KALTF vs. The Competition

Export to Excel
MetricClaritas PharmaceuticalsBiotechnology IndustryMedical SectorOTCMKTS Exchange
Market CapN/A$212.67M$4.31B$7.20B
Dividend YieldN/A2.56%5.98%18.04%
P/E RatioN/A368.9797.578.56
Price / SalesN/A22,899.953,427.75293.87
Price / CashN/A10.6827.0619.70
Price / BookN/A5.514.497.14
Net IncomeN/A-$18.27M$114.18M$723.67M
7 Day PerformanceN/A8.54%1.48%0.39%
1 Month PerformanceN/A0.16%-5.29%-1.82%
1 Year PerformanceN/A20.28%-15.53%-9.84%

Claritas Pharmaceuticals Competitors List

Export to Excel
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TRSBF
3SBio
0 of 5 stars		$0.80
flat		N/AN/A$0.00N/A0.005,292Short Interest ↓
ATTBF
Abattis Bioceuticals
0 of 5 stars		N/AN/AN/A$0.00N/A0.00N/A
ABCZF
Abcam
0 of 5 stars		C$13.50
flat		N/AN/AC$0.00N/A79.321,650
ADOIF
Adocia
0 of 5 stars		C$8.87
flat		C$11.00
+24.0%		N/AC$0.00N/A0.00N/A
AIMDW
Ainos
0 of 5 stars		$0.33
-26.8%		N/AN/A$0.00$2.51M0.00N/AGap Down
AGNPF
Algernon Pharmaceuticals
0 of 5 stars		$0.32
flat		N/A-74.0%$0.00N/A0.00N/AShort Interest ↑
Gap Down
AKBLF
ALK-Abelló A/S
0 of 5 stars		$14.00
flat		$150.00
+971.4%		N/A$0.00N/A0.002,537
LBTSF
Almirall
1.3126 of 5 stars		$9.68
flat		$11.50
+18.8%		N/A$0.00N/A-129.321,786
ALPX
Alopexx
0 of 5 stars		N/AN/AN/A$0.00N/A0.00N/AHigh Trading Volume
DRTSW
Alpha Tau Medical
0 of 5 stars		$0.28
flat		N/AN/A$0.00N/A0.00N/A
This page (OTCMKTS:KALTF) was last updated on 3/27/2023 by MarketBeat.com Staff